Dissecting Pivotal Research in Lower-Risk MDS From ASCO 2025 - Episode 3
How Data Are Defining the Role of Luspatercept in ESA-Naive, Lower-Risk MDS
Guillermo Garcia-Manero, MD, highlights clinical trial findings and real-world data for luspatercept in ESA-naive, lower-risk MDS.
Video Player is loading.
Related Content:
